Clinical Trial Update: Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating TQB2450 plus chemotherapy with or without Anlotinib for advanced endometrial cancer or uterine sarcoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Uterine Sarcoma

Drugs mentioned

• Anlotinib hydrochloride capsules (anlotinib hydrochloride)
• TQB2450

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Advanced Endometrial Cancer, Sarcoma of Uterus | Phase 2 | Status: TERMINATED